Susquehanna International Group, LLP Mereo Biopharma Group PLC Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Susquehanna International Group, LLP holds 174,378 shares of MREO stock, worth $392,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,378

Previous 391,590 55.47%

Holding current value

$392,350

Previous $1.37 Million 71.39%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$2.25 - $3.76 $488,727 - $816,717	-217,212 Reduced 55.47%	174,378 $392,000
Q4 2024 Feb 14, 2025	BUY	$3.29 - $4.62 $16,976 - $23,839	5,160 Added 1.34%	391,590 $1.37 Million
Q3 2024 Nov 14, 2024	SELL	$3.45 - $4.87 $1.57 Million - $2.21 Million	-453,834 Reduced 54.01%	386,430 $1.59 Million
Q2 2024 Aug 15, 2024	SELL	$2.58 - $4.25 $2.01 Million - $3.31 Million	-779,363 Reduced 48.12%	840,264 $3.02 Million
Q1 2024 May 07, 2024	BUY	$2.3 - $4.05 $3.32 Million - $5.85 Million	1,443,999 Added 822.19%	1,619,627 $5.34 Million
Q4 2023 Feb 14, 2024	BUY	$1.19 - $2.42 $86,106 - $175,106	72,358 Added 70.07%	175,628 $405,000
Q3 2023 Nov 14, 2023	BUY	$1.15 - $1.67 $118,760 - $172,460	103,270 New	103,270 $133,000
Q1 2023 May 16, 2023	BUY	$0.71 - $1.22 $21,292 - $36,586	29,989 Added 228.92%	43,089 $30,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $1.01 $19,412 - $39,213	-38,825 Reduced 74.77%	13,100 $9,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.73 $12,426 - $26,216	-15,154 Reduced 22.59%	51,925 $45,000
Q2 2022 Aug 15, 2022	BUY	$0.33 - $1.69 $1,696 - $8,689	5,142 Added 8.3%	67,079 $75,000
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.59 $35,266 - $60,489	23,355 Added 60.53%	61,937 $99,000
Q3 2021 Nov 15, 2021	BUY	$2.2 - $3.17 $38,396 - $55,326	17,453 Added 82.6%	38,582 $93,000
Q2 2021 Aug 11, 2021	BUY	$2.94 - $4.08 $15,214 - $21,114	5,175 Added 32.44%	21,129 $67,000
Q1 2021 May 17, 2021	BUY	$2.6 - $4.43 $41,480 - $70,676	15,954 New	15,954 $54,000

Others Institutions Holding MREO

# of Institutions

100

Shares Held

111M

Call Options Held

Put Options Held

668K

View Full List

About Mereo Biopharma Group plc

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $281M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

More about MREO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Mereo Biopharma Group PLC Transaction History